PHARMACOLOGICAL BRIDGE TO CARDIAC TRANSPLANTATION - CURRENT LIMITATIONS

被引：10

作者：

LOISANCE, DY ^{[1
]}

DELEUZE, PH ^{[1
]}

HOUEL, R ^{[1
]}

BENVENUTI, C ^{[1
]}

ELSAYED, A ^{[1
]}

MAZZUCOTELLI, JP ^{[1
]}

TARRAL, A ^{[1
]}

SAAL, JP ^{[1
]}

CACHERA, JP ^{[1
]}

机构：

[1] CHU HENRI MONDOR,FAC MED,SERV CARDIOL,F-94010 CRETEIL,FRANCE

来源：

ANNALS OF THORACIC SURGERY | 1993年 / 55卷 / 01期

关键词：

D O I：

10.1016/0003-4975(93)90543-Q

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Addition of intravenous enoximone to sympathomimetic agents permits a rapid and drastic improvement in the clinical and hemodynamical condition of patients in cardiogenic shock referred for a mechanical bridge to transplantation. The present experience, based on the management of 52 patients, permits us to point out the current limitations of this pharmacological bridge: the rate of sudden death, the incompleteness of the physical rehabilitation of the patients, and the vanishing effect of intravenous enoximone.

引用

页码：310 / 313

页数：4

共 7 条

[1] IRREVERSIBLE DROP OF SYSTEMIC VASCULAR RESISTANCES IN PATIENTS IMPLANTED WITH A JARVIK TOTAL ARTIFICIAL-HEART [J].

DELEUZE, P ;

LOISANCE, DY ;

SHIIYA, N ;

WAN, F ;

HILLION, ML ;

BENVENUTI, C ;

HEURTEMATTE, Y ;

CACHERA, JP .

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1991, 14 (05) :286-289

[2]

FRIEDEL N, IN PRESS EUR J CARDI

[3]

LEGALL JR, 1984, CRIT CARE MED, V12, P975

[4]

Loisance D, 1989, Eur J Cardiothorac Surg, V3, P196, DOI 10.1016/1010-7940(89)90066-3

[5]

LOISANCE D, 1990, T AM SOC ART INT ORG, V36, pM179

[6]

LOISANCE D, 1991, T AM SOC ART INT ORG, V37, pM125

[7]

MERLET P, 1992, J NUCL MED, V33, P471

← 1 →